Features, pricing, ratings, and pros & cons — compared head-to-head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). USB Keystroke Injection Protection is a free endpoint protection platform tool. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
USB Keystroke Injection Protection
Linux security teams managing physical access risks on shared workstations or kiosk deployments should use USB Keystroke Injection Protection because it blocks BadUSB attacks that traditional endpoint agents ignore. The tool runs as a lightweight daemon with 549 GitHub stars and addresses a gap in NIST Identify controls that most EDR platforms don't cover; it assumes devices are already on the network and trusted. This isn't for Windows or macOS environments, and it won't help if your threat model centers on software-based credential theft or lateral movement after initial compromise.
Tool that immunizes Windows systems against critical vulnerabilities
A daemon for blocking USB keystroke injection devices on Linux systems
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs USB Keystroke Injection Protection for your endpoint protection platform needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
USB Keystroke Injection Protection: A daemon for blocking USB keystroke injection devices on Linux systems..
Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.
360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). USB Keystroke Injection Protection is open-source with 549 GitHub stars. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.
360 High-Risk Vulnerability Immunization Tool V2.0 and USB Keystroke Injection Protection serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools. Key differences: 360 High-Risk Vulnerability Immunization Tool V2.0 is Commercial while USB Keystroke Injection Protection is Free, USB Keystroke Injection Protection is open-source. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox